Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neo-adjuvant Adaptive Master Trial for Localized Cancers With Rapid Evaluation of Molecular & Immune Status for Stratified Immunotherapies in Oncology

NCT07262489 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT07262489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07262489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neo-adjuvant Adaptive Master Trial for Localized Cancers With Rapid Evaluation of Molecular & Immune Status for Stratified Immunotherapies in Oncology
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Recruiting
Start date
January 21, 2026
Completion date
November 30, 2034
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized cancer